Nifty
Sensex
:
:
15752.05
52907.93
-28.20 (-0.18%)
-111.01 (-0.21%)

Pharmaceuticals & Drugs - Global

Rating :
47/99

BSE: 524404 | NSE: MARKSANS

43.50
01-Jul-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 44.25
  • 44.70
  • 43.20
  • 43.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  542850
  •  237.97
  •  93.60
  •  38.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,778.47
  • 9.51
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,584.92
  • 0.58%
  • 1.48

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 48.25%
  • 2.68%
  • 41.35%
  • FII
  • DII
  • Others
  • 3.46%
  • 0.46%
  • 3.80%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.49
  • 12.40
  • 11.23

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 59.48
  • 20.78

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 92.92
  • 45.59

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.98
  • 13.98
  • 10.37

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.23
  • 2.47
  • 2.29

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.05
  • 10.53
  • 7.00

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Net Sales
418.04
330.20
26.60%
362.63
358.36
1.19%
361.20
356.47
1.33%
348.96
331.15
5.38%
Expenses
354.40
234.82
50.92%
304.83
267.31
14.04%
301.10
273.31
10.17%
271.63
261.13
4.02%
EBITDA
63.64
95.37
-33.27%
57.80
91.06
-36.53%
60.10
83.16
-27.73%
77.34
70.02
10.45%
EBIDTM
15.22%
28.88%
15.94%
25.41%
16.64%
23.33%
22.16%
21.14%
Other Income
15.34
6.01
155.24%
12.06
-3.17
-
8.57
3.67
133.51%
5.88
0.18
3,166.67%
Interest
5.03
2.83
77.74%
0.95
1.68
-43.45%
1.50
1.93
-22.28%
0.97
1.55
-37.42%
Depreciation
21.36
1.33
1,506.02%
8.56
8.58
-0.23%
7.39
18.99
-61.08%
7.47
7.25
3.03%
PBT
52.60
97.22
-45.90%
60.35
77.64
-22.27%
59.78
65.90
-9.29%
74.78
61.40
21.79%
Tax
22.95
17.73
29.44%
12.08
18.70
-35.40%
13.49
15.16
-11.02%
12.18
12.04
1.16%
PAT
29.65
79.50
-62.70%
48.27
58.94
-18.10%
46.29
50.73
-8.75%
62.60
49.36
26.82%
PATM
7.09%
24.08%
13.31%
16.45%
12.81%
14.23%
17.94%
14.91%
EPS
0.72
1.94
-62.89%
1.18
1.44
-18.06%
1.13
1.24
-8.87%
1.53
1.21
26.45%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
1,490.83
1,376.18
1,134.21
1,000.07
912.69
767.16
893.33
796.69
630.00
438.42
355.55
Net Sales Growth
8.33%
21.33%
13.41%
9.57%
18.97%
-14.12%
12.13%
26.46%
43.70%
23.31%
 
Cost Of Goods Sold
716.81
595.05
567.83
498.01
523.13
458.74
509.69
445.44
367.93
252.86
212.92
Gross Profit
774.02
781.13
566.38
502.07
389.57
308.42
383.63
351.25
262.07
185.56
142.62
GP Margin
51.92%
56.76%
49.94%
50.20%
42.68%
40.20%
42.94%
44.09%
41.60%
42.32%
40.11%
Total Expenditure
1,231.96
1,036.57
941.96
867.92
834.31
734.24
760.91
620.86
516.04
369.02
455.33
Power & Fuel Cost
-
16.42
14.38
14.34
11.83
13.27
12.58
9.72
7.80
6.12
4.89
% Of Sales
-
1.19%
1.27%
1.43%
1.30%
1.73%
1.41%
1.22%
1.24%
1.40%
1.38%
Employee Cost
-
197.32
168.42
159.07
147.75
149.70
122.42
72.61
66.44
55.91
45.70
% Of Sales
-
14.34%
14.85%
15.91%
16.19%
19.51%
13.70%
9.11%
10.55%
12.75%
12.85%
Manufacturing Exp.
-
127.47
113.32
77.14
59.90
47.34
50.44
37.59
30.11
9.85
8.76
% Of Sales
-
9.26%
9.99%
7.71%
6.56%
6.17%
5.65%
4.72%
4.78%
2.25%
2.46%
General & Admin Exp.
-
50.67
45.52
51.03
42.51
37.52
36.01
15.35
16.13
24.93
21.00
% Of Sales
-
3.68%
4.01%
5.10%
4.66%
4.89%
4.03%
1.93%
2.56%
5.69%
5.91%
Selling & Distn. Exp.
-
33.54
32.15
68.36
49.14
27.66
29.77
34.47
27.63
22.84
17.39
% Of Sales
-
2.44%
2.83%
6.84%
5.38%
3.61%
3.33%
4.33%
4.39%
5.21%
4.89%
Miscellaneous Exp.
-
16.10
0.34
-0.01
0.05
0.00
0.00
5.67
0.00
-3.49
17.39
% Of Sales
-
1.17%
0.03%
0.00%
0.01%
0%
0%
0.71%
0%
-0.80%
40.69%
EBITDA
258.88
339.61
192.25
132.15
78.38
32.92
132.42
175.83
113.96
69.40
-99.78
EBITDA Margin
17.36%
24.68%
16.95%
13.21%
8.59%
4.29%
14.82%
22.07%
18.09%
15.83%
-28.06%
Other Income
41.85
6.69
0.33
4.62
8.47
18.85
12.72
12.23
7.28
4.40
2.05
Interest
8.45
7.99
8.75
9.66
10.22
6.78
10.16
16.05
19.13
14.60
53.58
Depreciation
44.78
36.15
26.66
22.80
26.84
30.09
28.13
16.13
15.69
15.65
23.70
PBT
247.51
302.16
157.17
104.31
49.80
14.90
106.85
155.88
86.41
43.55
-175.00
Tax
60.70
63.63
36.42
23.87
14.00
3.56
24.11
43.92
12.79
-5.28
1.08
Tax Rate
24.52%
21.06%
23.17%
22.88%
28.11%
23.89%
22.56%
28.18%
14.80%
-12.12%
-0.62%
PAT
186.81
235.94
117.02
76.46
32.94
8.83
78.51
109.39
71.90
45.89
-178.84
PAT before Minority Interest
186.81
238.54
120.75
80.44
35.80
11.33
82.74
111.96
73.62
48.83
-176.08
Minority Interest
0.00
-2.60
-3.73
-3.98
-2.86
-2.50
-4.23
-2.57
-1.72
-2.94
-2.76
PAT Margin
12.53%
17.14%
10.32%
7.65%
3.61%
1.15%
8.79%
13.73%
11.41%
10.47%
-50.30%
PAT Growth
-21.68%
101.62%
53.05%
132.12%
273.05%
-88.75%
-28.23%
52.14%
56.68%
-
 
EPS
4.56
5.76
2.86
1.87
0.80
0.22
1.92
2.67
1.76
1.12
-4.37

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
886.49
636.01
542.48
470.86
433.43
454.32
379.76
142.18
86.48
-168.07
Share Capital
40.93
40.93
40.93
40.93
40.93
53.43
53.43
52.03
52.03
50.28
Total Reserves
845.56
595.08
501.55
429.93
392.50
400.89
326.33
90.15
34.45
-219.51
Non-Current Liabilities
23.70
24.15
17.14
15.64
16.07
-1.91
1.46
22.16
10.49
28.26
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
19.82
7.88
15.20
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
2.11
1.47
1.36
1.08
0.96
0.00
0.00
0.00
0.00
0.00
Current Liabilities
298.40
228.75
232.62
234.68
296.06
259.43
286.24
319.12
297.28
519.26
Trade Payables
168.66
110.33
106.07
77.83
161.78
118.98
107.02
83.18
56.06
58.62
Other Current Liabilities
79.12
58.86
20.90
10.08
0.71
0.68
39.88
96.58
108.73
336.39
Short Term Borrowings
18.74
18.84
99.91
117.41
109.71
87.89
82.19
105.54
113.79
113.92
Short Term Provisions
31.88
40.72
5.74
29.36
23.85
51.88
57.15
33.82
18.70
10.32
Total Liabilities
1,227.45
902.02
802.46
730.73
751.81
720.20
675.56
490.10
401.24
385.07
Net Block
309.36
302.72
269.73
279.38
266.98
269.65
165.90
145.65
156.12
165.35
Gross Block
607.09
565.39
506.26
495.35
456.49
429.47
297.78
261.70
256.88
250.51
Accumulated Depreciation
297.73
262.67
236.54
215.97
189.52
159.82
131.89
116.05
100.76
85.15
Non Current Assets
325.20
308.45
271.02
280.19
267.92
280.06
166.72
147.15
157.32
169.44
Capital Work in Progress
11.68
0.00
0.00
0.00
0.36
0.00
0.00
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
4.16
5.73
1.29
0.82
0.59
10.41
0.83
1.50
1.20
4.08
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
902.25
593.59
531.44
450.54
483.88
440.15
508.83
342.95
243.93
215.63
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
404.32
241.84
293.25
218.12
190.09
167.79
130.11
102.59
77.69
73.36
Sundry Debtors
271.38
243.35
176.60
176.91
247.58
217.29
183.45
169.61
131.31
112.77
Cash & Bank
212.29
93.73
33.54
39.88
25.16
35.30
185.27
46.95
15.88
22.39
Other Current Assets
14.27
11.26
28.06
15.63
21.05
19.76
10.01
23.80
19.04
7.11
Short Term Loans & Adv.
0.98
3.40
0.00
0.00
20.96
19.76
10.01
23.80
19.04
7.11
Net Current Assets
603.85
364.83
298.82
215.86
187.82
180.71
222.60
23.83
-53.36
-303.63
Total Assets
1,227.45
902.04
802.46
730.73
751.80
720.21
675.55
490.10
401.25
385.07

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
178.74
233.33
27.40
50.09
14.06
30.80
154.51
64.84
38.56
-62.30
PBT
302.16
157.17
104.31
49.80
14.90
106.85
109.40
71.91
45.88
-178.84
Adjustment
75.13
42.04
31.88
43.99
26.58
39.63
24.26
19.57
27.85
124.15
Changes in Working Capital
-150.03
59.12
-81.79
-36.23
-6.04
-88.14
20.27
-26.01
-35.18
-7.60
Cash after chg. in Working capital
227.27
258.33
54.40
57.56
35.44
58.34
153.94
65.47
38.56
-62.30
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-48.53
-25.00
-27.00
-7.46
-21.37
-27.54
-0.89
-0.27
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-44.90
-59.58
-13.48
-38.81
-20.73
-123.01
-33.19
-4.49
-5.43
-3.25
Net Fixed Assets
-28.48
-23.87
-23.07
-5.86
-11.49
-22.01
-32.23
-2.62
-4.85
90.35
Net Investments
0.00
0.00
0.00
-1.78
-2.85
-163.82
0.00
0.00
-44.11
44.11
Others
-16.42
-35.71
9.59
-31.17
-6.39
62.82
-0.96
-1.87
43.53
-137.71
Cash from Financing Activity
-15.29
-113.55
-20.78
3.38
-3.47
-57.75
16.99
-29.28
-39.64
57.02
Net Cash Inflow / Outflow
118.56
60.19
-6.86
14.67
-10.14
-149.96
138.32
31.07
-6.51
-8.53
Opening Cash & Equivalents
93.73
33.54
39.72
25.05
35.30
185.27
46.95
15.88
22.39
30.92
Closing Cash & Equivalent
212.29
93.73
32.85
39.72
25.16
35.30
185.27
46.95
15.88
22.39

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
21.66
15.54
13.25
11.50
10.59
10.79
8.97
3.34
1.89
-4.97
ROA
22.40%
14.17%
10.49%
4.83%
1.54%
11.86%
19.21%
16.52%
12.42%
-40.16%
ROE
31.33%
20.49%
15.88%
7.92%
2.59%
20.45%
45.15%
73.02%
0.00%
0.00%
ROCE
39.76%
25.57%
18.51%
10.60%
3.99%
23.16%
44.64%
38.30%
44.72%
-180.20%
Fixed Asset Turnover
2.35
2.12
2.00
1.92
1.73
2.46
2.85
2.43
1.73
1.20
Receivable days
68.26
67.57
64.51
84.88
110.59
81.87
80.88
87.17
101.60
108.63
Inventory Days
85.69
86.10
93.32
81.63
85.14
60.86
53.30
52.22
62.88
72.16
Payable days
85.57
45.09
38.48
55.10
65.56
54.58
56.06
48.85
59.34
68.51
Cash Conversion Cycle
68.38
108.58
119.35
111.40
130.17
88.15
78.13
90.54
105.14
112.28
Total Debt/Equity
0.02
0.03
0.18
0.25
0.25
0.19
0.23
1.12
1.88
-1.06
Interest Cover
38.83
18.97
11.80
5.87
3.20
11.52
10.72
5.52
3.98
-2.27

Top Investors:

News Update:


  • Marksans Pharma’s arm recalls Kroger Brand Aspirin and Ibuprofen bottles
    21st Jun 2022, 12:48 PM

    Total 12 lots containing 209,430 units have been recalled

    Read More
  • Marksans Pharma acquires entire stake in Access Healthcare
    10th Jun 2022, 14:22 PM

    Earlier, in April 2022, the company had signed a share purchase agreement to acquire a 100% stake in Access Healthcare

    Read More
  • Marksans Pharma inks pact to acquire 100% stake in Access Healthcare for Medical Products
    25th Apr 2022, 14:24 PM

    This transaction was approved by the Board of Directors of the company on April 23, 2022

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.